| Phase 4 |
| NCT06344091 |
A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients |
Local Analgesia Via Infiltration |
Recruiting |
2026-09-28 |
| Phase 3 |
| NCT07286032 |
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in… |
Patients With Chemotherapy-Induced Thrombocytopenia |
Recruiting |
2026-10-01 |
| NCT07746726 |
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus… |
Neuromuscular Blockade |
Recruiting |
2026-09-22 |
| NCT07232875 |
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line… |
KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting |
Recruiting |
2026-07-15 |
| NCT05884255 |
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With… |
Advanced Gastroenteropancreatic Neuroendocrine Tumor |
Recruiting |
2026-05-19 |
| NCT07241416 |
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive… |
Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
Recruiting |
2026-05-11 |
| NCT06828354 |
A Study of SHR-A1811 in Subjects With Ovarian Cancer |
Ovarian Cancer |
Recruiting |
2026-04-20 |
| NCT07311694 |
A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in… |
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer |
Recruiting |
2026-02-04 |
| NCT06430437 |
A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic… |
Non-Small Cell Lung Cancer With HER2- Mutations |
Recruiting |
2026-01-21 |
| NCT04342910 |
Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With… |
Gastric Cancer |
Recruiting |
2026-01-20 |
| NCT06122389 |
SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma |
Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy |
Recruiting |
2026-01-08 |
| NCT07238283 |
Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV… |
First-line Treatment of Metastatic Pancreatic Cancer |
Recruiting |
2025-12-09 |
| NCT06123494 |
SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction… |
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma |
Recruiting |
2024-01-16 |
| NCT04316364 |
A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable… |
Non-Small-Cell Lung Cancer |
Recruiting |
2021-11-04 |
| NCT06057610 |
A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive… |
HER2-PositiveRecurrent or Metastatic Breast Cancer |
Active, Not Recruiting |
2026-09-09 |
| NCT04957550 |
To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic… |
Psoriatic Arthritis |
Active, Not Recruiting |
2026-08-28 |
| NCT07790380 |
FH-006 Versus Investigator's Choice of Chemotherapy in Patients With Locally Advanced… |
Locally Advanced, Recurrent or Metastatic ESCC Patients Who Have Failed Prior PD-1/PD-L1 Inhibitors Combined With Platinum-based Chemotherapy |
Not Yet Recruiting |
2026-08-27 |
| NCT03980054 |
A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With… |
Breast Cancer |
Active, Not Recruiting |
2026-08-17 |
| NCT05814354 |
SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer… |
Breast Cancer |
Active, Not Recruiting |
2026-08-06 |
| NCT07196774 |
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in… |
Early-stage or Locally Advanced HER2-positive Breast Cancer |
Active, Not Recruiting |
2026-07-30 |
| NCT06126640 |
A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in… |
HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy |
Active, Not Recruiting |
2026-06-30 |
| NCT04639180 |
A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in… |
Hepatocellular Carcinoma (HCC) |
Active, Not Recruiting |
2025-12-30 |
| NCT05320692 |
A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With… |
Hepatocellular Carcinoma |
Active, Not Recruiting |
2025-12-11 |
| NCT04906993 |
Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic… |
Cervical Cancer |
Active, Not Recruiting |
2025-09-09 |
| NCT05424835 |
A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive… |
HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane |
Active, Not Recruiting |
2025-08-22 |